{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:42:14Z","timestamp":1789728134219,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jchromb.2024.124308","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T21:42:51Z","timestamp":1726177371000},"page":"124308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Development and validation of an LC-MS\/MS method for simultaneous quantification of eight drugs in plasma and brain: Application in a pharmacokinetic study in mice"],"prefix":"10.1016","volume":"1247","author":[{"given":"Aristeidis","family":"Lentzas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikkie","family":"Venekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"van Tellingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124308_b0005","article-title":"The impact of ATP-binding cassette transporters in the diseased brain: Context matters","volume":"5","author":"Baltira","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jchromb.2024.124308_b0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/pharmrev.120.000025","article-title":"ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery","volume":"75","author":"Schulz","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jchromb.2024.124308_b0015","doi-asserted-by":"crossref","unstructured":"R.P. Dash, R. Jayachandra Babu, N.R. Srinivas, Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies, Eur J Drug Metab Pharmacokinet, 42 (2017) 915-933. doi: 10.1007\/s13318-017-0411-4.","DOI":"10.1007\/s13318-017-0411-4"},{"key":"10.1016\/j.jchromb.2024.124308_b0020","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/jm8013822","article-title":"Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar","volume":"52","author":"Kuhnle","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jchromb.2024.124308_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010666","article-title":"Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines","volume":"24","author":"Linke","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2024.124308_b0030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/acn3.141","article-title":"Inhibiting drug efflux transporters improves efficacy of ALS therapeutics","volume":"1","author":"Jablonski","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jchromb.2024.124308_b0035","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1124\/dmd.113.055566","article-title":"Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution","volume":"42","author":"Montesinos","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2024.124308_b0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/jcbfm.2015.19","article-title":"Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study","volume":"35","author":"Bauer","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jchromb.2024.124308_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.112.192195","article-title":"Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032)","volume":"342","author":"Mittapalli","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2024.124308_b0050","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1158\/0008-5472.CAN-07-2686","article-title":"Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance","volume":"67","author":"Shi","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2024.124308_b0055","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2967\/jnumed.117.195800","article-title":"Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood-Brain Barrier Using Elacridar and (11)C-Erlotinib PET","volume":"59","author":"Verheijen","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jchromb.2024.124308_b0060","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1177\/0271678X20965500","article-title":"Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1\/ABCG2 substrate [(11)C]erlotinib","volume":"41","author":"Tournier","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jchromb.2024.124308_b0065","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/rcm.6654","article-title":"Quantification of docetaxel and its metabolites in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"27","author":"Hendrikx","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2024.124308_b0070","doi-asserted-by":"crossref","unstructured":"T. Arafat, B. Arafat, R. awad, A.A. awwad, Determination of loperamide in human plasma and saliva by liquid chromatography-tandem mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 972 (2014) 81-88. doi: 10.1016\/j.jchromb.2014.09.037.","DOI":"10.1016\/j.jchromb.2014.09.037"},{"key":"10.1016\/j.jchromb.2024.124308_b0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpba.2017.08.045","article-title":"UPLC-MS\/MS assay of riluzole in human plasma and cerebrospinal fluid (CSF): Application in samples from spinal cord injured patients","volume":"146","author":"Sarkar","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124308_b0080","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/jms.687","article-title":"Quantitative analysis of the P-glycoprotein inhibitor Elacridar (GF120918) in human and dog plasma using liquid chromatography with tandem mass spectrometric detection","volume":"39","author":"Stokvis","year":"2004","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2024.124308_b0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/FTD.0000000000000110","article-title":"Development and validation of a rapid and simple LC-MS\/MS method for quantification of vemurafenib in human plasma: application to a human pharmacokinetic study","volume":"37","author":"Bihan","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2024.124308_b0090","doi-asserted-by":"crossref","unstructured":"C.B.N.C. do, G.D. Mendes, R.E. Barrientos-Astigarraga, P. Galvinas, C.H. Oliveira, G. De Nucci, Verapamil quantification in human plasma by liquid chromatography coupled to tandem mass spectrometry. An application for bioequivalence study, J Chromatogr B Analyt Technol Biomed Life Sci, 827 (2005) 165-172. doi: 10.1016\/j.jchromb.2005.07.012.","DOI":"10.1016\/j.jchromb.2005.07.012"},{"key":"10.1016\/j.jchromb.2024.124308_b0095","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/jssc.202101013","article-title":"Quantification of vincristine and tariquidar by liquid chromatography-tandem mass spectrometry in mouse whole blood using volumetric absorptive microsampling for pharmacokinetic applications","volume":"45","author":"Rosser","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2024.124308_b0100","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1021\/ac5018265","volume":"86","author":"Gu","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124308_b0105","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1021\/ac070054s","article-title":"Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multianalyte assays for quantification of drugs in human plasma","volume":"79","author":"Peters","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124308_b0110","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4155\/bio-2019-0149","article-title":"Recommendations and best practices for calibration curves in quantitative LC-MS bioanalysis","volume":"11","author":"Fu","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2024.124308_b0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.aca.2014.01.036","article-title":"Impact of calibrator concentrations and their distribution on accuracy of quadratic regression for liquid chromatography-mass spectrometry bioanalysis","volume":"815","author":"Tan","year":"2014","journal-title":"Anal. Chim. Acta"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224003179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224003179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T23:21:38Z","timestamp":1737328898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224003179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":23,"alternative-id":["S1570023224003179"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124308","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MS\/MS method for simultaneous quantification of eight drugs in plasma and brain: Application in a pharmacokinetic study in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124308"}}